Total investments received (USD): 40.71m
Round value (USD): 21.07m
Company: NeoPhore
Industry:
Biotech
Health services










Belgium
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Spain